
    
      Data will be collected from the medical files retro- and prospectively. If patients are still
      under treatment at study initiation and have not yet completed 24 months of treatment with
      intravitreal aflibercept in a treat-and-extend regimen, data of the remaining observation
      period will be collected prospectively.
    
  